speb/financial-data huggingface dataset:
MSF.DE cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 1866000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Issuance Of Debt: 0.00
MSF.DE balance_sheet (annual, 2023-06-30) — Land And Improvements: 5683000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Leases: 8537000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 12728000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Long Term Debt: 41990000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 54718000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 0.00
MSF.DE cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -2750000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Long Term Equity Investment: 9879000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 81207000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Business Purchase And Sale: -1670000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: -20379000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Net Debt: 12533000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Income: 72361000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 72361000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 72361000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 72361000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 72361000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: 72361000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 72361000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Interest Income: 1026000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: 10213000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -2750000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -2750000000.00
MSF.DE income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 1026000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -1006000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Other Investing Changes: -3116000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Net PPE: 109987000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -28107000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Net Short Term Debt Issuance: 0.00
MSF.DE balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 128971000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Non Current Deferred Liabilities: 3345000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Non Current Deferred Revenue: 2912000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Liabilities: 433000000.00
MSF.DE income_statement (annual, 2023-06-30) — Normalized EBITDA: 105155000000.00
MSF.DE income_statement (annual, 2023-06-30) — Normalized Income: 72373150000.00
MSF.DE cash_flow (annual, 2023-06-30) — Operating Cash Flow: 87582000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Operating Gains Losses: 469000000.00
MSF.DE income_statement (annual, 2023-06-30) — Operating Income: 88523000000.00
MSF.DE income_statement (annual, 2023-06-30) — Operating Revenue: 211915000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 7432000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Current Assets: 21807000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 5247000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Current Liabilities: 14745000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: -6343000000.00
MSF.DE income_statement (annual, 2023-06-30) — Other Gand A: 7575000000.00
MSF.DE income_statement (annual, 2023-06-30) — Other Income Expense: -238000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 9366000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 30601000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Non Current Liabilities: 17981000000.00
MSF.DE income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: -223000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Properties: 14346000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 76552000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Payables: 22247000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 22247000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 11009000000.00
MSF.DE income_statement (annual, 2023-06-30) — Pretax Income: 89311000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Properties: 0.00
MSF.DE cash_flow (annual, 2023-06-30) — Purchase Of Business: -1670000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Purchase Of Investment: -37651000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Purchase Of PPE: -28107000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Raw Materials: 709000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Receivables: 48688000000.00
MSF.DE income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 65863000000.00
MSF.DE income_statement (annual, 2023-06-30) — Reconciled Depreciation: 13861000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Repayment Of Debt: -2750000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -22245000000.00
MSF.DE income_statement (annual, 2023-06-30) — Research And Development: 27195000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Retained Earnings: 118848000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Sale Of Investment: 47864000000.00
MSF.DE income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 22759000000.00
MSF.DE income_statement (annual, 2023-06-30) — Selling General And Administration: 30334000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Share Issued: 7432000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Short Term Debt Issuance: 0.00
MSF.DE income_statement (annual, 2023-06-30) — Special Income Charges: -30000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Stock Based Compensation: 9611000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Stockholders Equity: 206223000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Tangible Book Value: 128971000000.00
MSF.DE income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: -2850000.00
MSF.DE income_statement (annual, 2023-06-30) — Tax Provision: 16950000000.00
MSF.DE income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.19
MSF.DE balance_sheet (annual, 2023-06-30) — Total Assets: 411976000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Total Capitalization: 248213000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Total Debt: 59965000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 206223000000.00
MSF.DE income_statement (annual, 2023-06-30) — Total Expenses: 123392000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 205753000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 227719000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 101604000000.00
MSF.DE income_statement (annual, 2023-06-30) — Total Operating Income As Reported: 88523000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Total Tax Payable: 4152000000.00
MSF.DE income_statement (annual, 2023-06-30) — Total Unusual Items: -15000000.00
MSF.DE income_statement (annual, 2023-06-30) — Total Unusual Items Excluding Goodwill: -15000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Tradeand Other Payables Non Current: 25560000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Unrealized Gain Loss On Investment Securities: -303000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Work In Process: 23000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Working Capital: 80108000000.00
MSF.DE income_statement (annual, 2023-06-30) — Write Off: 30000000.00
MSF.DE income_statement (annual, 2024-06-30) — +Operating Expense: 61575000000.00
MSF.DE income_statement (annual, 2024-06-30) — +Total Revenue: 245122000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Accounts Payable: 21996000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Accounts Receivable: 56924000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -76421000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Allowance For Doubtful Accounts Receivable: -830000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Asset Impairment Charge: 206000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Available For Sale Securities: 1500000000.00
MSF.DE income_statement (annual, 2024-06-30) — Basic Average Shares: 7431000000.00
MSF.DE income_statement (annual, 2024-06-30) — Basic EPS: 11.86
MSF.DE cash_flow (annual, 2024-06-30) — Beginning Cash Position: 34704000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Buildings And Improvements: 93943000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Capital Expenditure: -44477000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 15497000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Capital Stock: 100923000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 18315000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 75531000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Cash Dividends Paid: -21771000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Cash Equivalents: 6744000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Cash Financial: 11571000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: -37757000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -96970000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Operating Activities: 118548000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Account Payable: 3545000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Income Tax Payable: 1687000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Inventory: 1284000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Other Current Assets: -8465000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Other Current Liabilities: 5616000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Other Working Capital: 7035000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Payable: 3545000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Payables And Accrued Expense: 3545000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Receivables: -7191000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Tax Payable: 1687000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Change In Working Capital: 1824000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Changes In Account Receivables: -7191000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Changes In Cash: -16179000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Commercial Paper: 6693000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Common Stock: 100923000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Common Stock Dividend Paid: -21771000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Common Stock Equity: 268477000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Common Stock Issuance: 2002000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Common Stock Payments: -17254000000.00
MSF.DE income_statement (annual, 2024-06-30) — Cost Of Revenue: 74114000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Current Assets: 159734000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Current Debt: 8942000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 8942000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 57582000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Current Deferred Revenue: 57582000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Current Liabilities: 125286000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Deferred Income Tax: -4738000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Deferred Tax: -4738000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Depreciation: 22287000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Depreciation Amortization Depletion: 22287000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Depreciation And Amortization: 22287000000.00
MSF.DE income_statement (annual, 2024-06-30) — Diluted Average Shares: 7469000000.00
MSF.DE income_statement (annual, 2024-06-30) — Diluted EPS: 11.80
MSF.DE income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: 88136000000.00
MSF.DE income_statement (annual, 2024-06-30) — EBIT: 110722000000.00
MSF.DE income_statement (annual, 2024-06-30) — EBITDA: 133009000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: -210000000.00
MSF.DE cash_flow (annual, 2024-06-30) — End Cash Position: 18315000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Financial Assets: 0.00
MSF.DE cash_flow (annual, 2024-06-30) — Financing Cash Flow: -37757000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Finished Goods: 845000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Free Cash Flow: 74071000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Gain Loss On Investment Securities: 245000000.00
MSF.DE income_statement (annual, 2024-06-30) — Gain On Sale Of Security: -343000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: -5590000000.00
MSF.DE income_statement (annual, 2024-06-30) — General And Administrative Expense: 7609000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Goodwill: 119220000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 146817000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Gross Accounts Receivable: 57754000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Gross PPE: 230973000000.00
MSF.DE income_statement (annual, 2024-06-30) — Gross Profit: 171008000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Hedging Assets Current: 12000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Income Tax Payable: 5017000000.00
MSF.DE income_statement (annual, 2024-06-30) — Interest Expense: 2935000000.00
MSF.DE income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 2935000000.00
MSF.DE income_statement (annual, 2024-06-30) — Interest Income: 3157000000.00
MSF.DE income_statement (annual, 2024-06-30) — Interest Income Non Operating: 3157000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Inventory: 1246000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Invested Capital: 320107000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Investing Cash Flow: -96970000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Investmentin Financial Assets: 1500000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Investments And Advances: 14600000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 2002000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Issuance Of Debt: 24395000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Land And Improvements: 8163000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Leases: 9594000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 15497000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Long Term Debt: 42688000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 58185000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 24395000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -29070000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Long Term Equity Investment: 13100000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 100312000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: -69132000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: -15252000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Net Debt: 33315000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Income: 88136000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 88136000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 88136000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 88136000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 88136000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: 88136000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 88136000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Interest Income: 222000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: 17937000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 575000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -4675000000.00
MSF.DE income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 222000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -1309000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Other Investing Changes: -1298000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Net PPE: 154552000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -44477000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Net Short Term Debt Issuance: 5250000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 121660000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Non Current Deferred Liabilities: 5220000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Non Current Deferred Revenue: 2602000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Liabilities: 2618000000.00
MSF.DE income_statement (annual, 2024-06-30) — Normalized EBITDA: 133558000000.00
MSF.DE income_statement (annual, 2024-06-30) — Normalized Income: 88585082000.00
MSF.DE cash_flow (annual, 2024-06-30) — Operating Cash Flow: 118548000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Operating Gains Losses: 245000000.00
MSF.DE income_statement (annual, 2024-06-30) — Operating Income: 109433000000.00
MSF.DE income_statement (annual, 2024-06-30) — Operating Revenue: 245122000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 7434138859.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Current Assets: 26021000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 2249000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Current Liabilities: 19185000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: -5590000000.00
MSF.DE income_statement (annual, 2024-06-30) — Other Gand A: 7609000000.00
MSF.DE income_statement (annual, 2024-06-30) — Other Income Expense: -1868000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 27597000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 36460000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Non Current Liabilities: 27064000000.00
MSF.DE income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: -1319000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Properties: 18961000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 57216000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Payables: 27013000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 27013000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 12564000000.00
MSF.DE income_statement (annual, 2024-06-30) — Pretax Income: 107787000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Properties: 0.00
MSF.DE cash_flow (annual, 2024-06-30) — Purchase Of Business: -69132000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Purchase Of Investment: -17732000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Purchase Of PPE: -44477000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Raw Materials: 394000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Receivables: 56924000000.00
MSF.DE income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 74114000000.00
MSF.DE income_statement (annual, 2024-06-30) — Reconciled Depreciation: 22287000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Repayment Of Debt: -29070000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -17254000000.00
MSF.DE income_statement (annual, 2024-06-30) — Research And Development: 29510000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Retained Earnings: 173144000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Sale Of Investment: 35669000000.00
MSF.DE income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 24456000000.00
MSF.DE income_statement (annual, 2024-06-30) — Selling General And Administration: 32065000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Share Issued: 7434138859.00
MSF.DE cash_flow (annual, 2024-06-30) — Short Term Debt Issuance: 5250000000.00
MSF.DE income_statement (annual, 2024-06-30) — Special Income Charges: -206000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Stock Based Compensation: 10734000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Stockholders Equity: 268477000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Tangible Book Value: 121660000000.00
MSF.DE income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: -99918000.00
MSF.DE income_statement (annual, 2024-06-30) — Tax Provision: 19651000000.00
MSF.DE income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.18
MSF.DE balance_sheet (annual, 2024-06-30) — Total Assets: 512163000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Total Capitalization: 311165000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Total Debt: 67127000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 268477000000.00
MSF.DE income_statement (annual, 2024-06-30) — Total Expenses: 135689000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 243686000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 352429000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 118400000000.00
MSF.DE income_statement (annual, 2024-06-30) — Total Operating Income As Reported: 109433000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Total Tax Payable: 5017000000.00
MSF.DE income_statement (annual, 2024-06-30) — Total Unusual Items: -549000000.00
MSF.DE income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: -549000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Tradeand Other Payables Non Current: 27931000000.00
MSF.DE cash_flow (annual, 2024-06-30) — Unrealized Gain Loss On Investment Securities: -146000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Work In Process: 7000000.00
MSF.DE balance_sheet (annual, 2024-06-30) — Working Capital: 34448000000.00
MSF.DE income_statement (annual, 2024-06-30) — Write Off: 206000000.00
MSF.DE cash_flow (quarterly, 2024-09-30) — Change In Income Tax Payable: 1016000000.00
MSF.DE cash_flow (quarterly, 2024-09-30) — Change In Tax Payable: 1016000000.00
MSF.DE balance_sheet (quarterly, 2024-09-30) — Commercial Paper: 0.00
MSF.DE balance_sheet (quarterly, 2024-09-30) — Finished Goods: 1127000000.00
MSF.DE cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
MSF.DE cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
MSF.DE balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 14278000000.00
MSF.DE balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 2249000000.00
MSF.DE balance_sheet (quarterly, 2024-09-30) — Raw Materials: 488000000.00
MSF.DE balance_sheet (quarterly, 2024-09-30) — Work In Process: 11000000.00
MSF.DE cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 867000000.00
MSF.DE income_statement (quarterly, 2024-12-31) — Basic Average Shares: 7435000000.00
MSF.DE income_statement (quarterly, 2024-12-31) — Basic EPS: 3.24
MSF.DE cash_flow (quarterly, 2024-12-31) — Change In Income Tax Payable: -3395000000.00
MSF.DE cash_flow (quarterly, 2024-12-31) — Change In Tax Payable: -3395000000.00
MSF.DE balance_sheet (quarterly, 2024-12-31) — Commercial Paper: 0.00
MSF.DE income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 7468000000.00
MSF.DE income_statement (quarterly, 2024-12-31) — Diluted EPS: 3.23
MSF.DE balance_sheet (quarterly, 2024-12-31) — Finished Goods: 557000000.00
MSF.DE cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 134000000.00
MSF.DE cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
MSF.DE cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
MSF.DE balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 13304000000.00
MSF.DE balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 5248000000.00
MSF.DE balance_sheet (quarterly, 2024-12-31) — Raw Materials: 345000000.00
MSF.DE cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
MSF.DE cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -25000000.00
MSF.DE balance_sheet (quarterly, 2024-12-31) — Work In Process: 7000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — +Operating Expense: 16147000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — +Total Revenue: 70066000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 26250000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 51700000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -87074000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -695000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 24000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 2275000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 7434000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Basic EPS: 3.47
MSF.DE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 17482000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -16745000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 17686000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 106965000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 28828000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 79612000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -6169000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 18148000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Cash Financial: 10680000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -13036000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -12714000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 36038000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1179000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 1298000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Inventory: 52000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 558000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 2448000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 266000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Payable: 1179000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1179000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2461000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 1298000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2042000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -2461000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 11294000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Commercial Paper: 0.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Common Stock: 106965000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -6169000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 321891000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 546000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -4781000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 21919000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Current Assets: 156644000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Current Debt: 2999000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2999000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 44636000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 44636000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 114206000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -2244000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Deferred Tax: -2244000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Depreciation: 7734000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7734000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7734000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 7461000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.46
MSF.DE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 25824000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — EBIT: 31971000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — EBITDA: 39705000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 52000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — End Cash Position: 28828000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Financial Assets: 273000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -13036000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Finished Goods: 508000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 20299000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -187000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 411000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4833000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1737000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Goodwill: 119329000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 143297000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 52395000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 295488000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Gross Profit: 48147000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 6000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 6805000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Interest Expense: 594000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 594000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Interest Income: 597000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 597000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Inventory: 848000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 364772000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -12714000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 2275000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 15762000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 546000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 17686000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 39882000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 57568000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2250000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 13487000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -981000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -4235000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Net Debt: 14053000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Income: 25824000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 25824000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 25824000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 25824000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 25824000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 25824000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 25824000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Interest Income: 3000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 4408000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2250000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -2250000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -382000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 604000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Net PPE: 208414000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -16745000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 178594000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 5362000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 2840000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2522000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 39318000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Normalized Income: 25506660000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 37044000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -187000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Operating Income: 32000000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Operating Revenue: 70066000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 7433982235.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 24478000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 2999000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 22937000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -4833000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Other Gand A: 1737000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Other Income Expense: -626000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 23968000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1006000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 38234000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 38536000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1013000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Properties: 295488000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 50784000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Payables: 33055000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 33055000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10579000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Pretax Income: 31377000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -981000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -4474000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -16745000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Raw Materials: 327000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Receivables: 51700000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 21919000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7734000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2250000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -4781000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Research And Development: 8198000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 219759000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 8882000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 6212000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7949000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Share Issued: 7433982235.00
MSF.DE income_statement (quarterly, 2025-03-31) — Special Income Charges: -24000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2980000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 321891000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 178594000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 69660000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Tax Provision: 5553000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.18
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Assets: 562624000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 361773000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Debt: 60567000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 321891000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Total Expenses: 38066000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 240733000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 405980000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 126527000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 32000000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 6805000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Total Unusual Items: 387000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 387000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 25061000000.00
MSF.DE cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -135000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Work In Process: 13000000.00
MSF.DE balance_sheet (quarterly, 2025-03-31) — Working Capital: 42438000000.00
MSF.DE income_statement (quarterly, 2025-03-31) — Write Off: 24000000.00
MSF.DE income_statement (annual, 2025-06-30) — +Operating Expense: 65365000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — +Operating Expense: 18104000000.00
MSF.DE income_statement (annual, 2025-06-30) — +Total Revenue: 281724000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — +Total Revenue: 76441000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Accounts Payable: 27724000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 27724000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Accounts Receivable: 69905000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 69905000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -93653000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -93653000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -944000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -944000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Asset Impairment Charge: 943000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 45000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Available For Sale Securities: 2460000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 2460000000.00
MSF.DE income_statement (annual, 2025-06-30) — Basic Average Shares: 7433000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 7432000000.00
MSF.DE income_statement (annual, 2025-06-30) — Basic EPS: 13.70
MSF.DE income_statement (quarterly, 2025-06-30) — Basic EPS: 3.66
MSF.DE cash_flow (annual, 2025-06-30) — Beginning Cash Position: 18315000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 28828000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Buildings And Improvements: 137921000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 137921000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Capital Expenditure: -64551000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -17079000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Capital Lease Obligations: 17437000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 17437000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Capital Stock: 109095000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 109095000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 30242000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 30242000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 94555000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 94555000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Cash Dividends Paid: -24082000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -6169000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Cash Equivalents: 18531000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 18531000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Cash Financial: 11711000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Cash Financial: 11711000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: -51699000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -10844000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: -72599000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -30572000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Operating Activities: 136162000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 42647000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Account Payable: 569000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -652000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Inventory: 309000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Inventory: -81000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Other Current Assets: -5994000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -3268000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Other Current Liabilities: 4947000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 4079000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Other Working Capital: 5400000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 19404000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Payable: 569000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Payable: -652000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Payables And Accrued Expense: 569000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -652000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Receivables: -10581000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Receivables: -16179000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Change In Working Capital: -5350000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 3303000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Changes In Account Receivables: -10581000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -16179000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Changes In Cash: 11864000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1231000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Commercial Paper: 0.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Commercial Paper: 0.00
MSF.DE balance_sheet (annual, 2025-06-30) — Common Stock: 109095000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 109095000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Common Stock Dividend Paid: -24082000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -6169000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Common Stock Equity: 343479000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 343479000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Common Stock Issuance: 2056000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 548000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Common Stock Payments: -18420000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -4546000000.00
MSF.DE income_statement (annual, 2025-06-30) — Cost Of Revenue: 87831000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 24014000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Current Assets: 191131000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 191131000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Current Debt: 2999000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Current Debt: 2999000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Current Debt And Capital Lease Obligation: 2999000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2999000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 64555000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 64555000000.00